Analyst Reco. Patterson Companies, Inc.

Equities

PDCO

US7033951036

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets 01:30:00 17/04/2025 am IST			5-day change	1st Jan Change
31.33 ^USD	+0.03%		-.--%	-

08/01	Patterson Companies, Inc. Appoints Patrik Eriksson as North American President of Patterson Dental	CI
22/25/22	Patterson Companies, Inc. Announces Chief Executive Officer Changes	CI

Analyst Reco.

17/24/17	Morgan Stanley Adjusts Price Target on Patterson Companies to $31.35 From $27	MT
17/24/17	UBS Adjusts Price Target on Patterson Companies to $31.35 From $24, Keeps Neutral Rating	MT
04/24/04	Mizuho Initiates Patterson Companies at Neutral With $24 Price Target	MT
03/24/03	Leerink Partners Adjusts Patterson Companies Price Target to $28 From $30, Maintains Outperform Rating	MT
05/24/05	UBS Adjusts Patterson Companies Price Target to $24 From $27, Maintains Neutral Rating	MT
29/24/29	Evercore ISI Trims Price Target on Patterson to $23 From $25, Keeps In Line Rating	MT
09/24/09	Evercore ISI Cuts Price Target on Patterson Companies to $25 From $27, Maintains In-Line Rating	MT
20/24/20	Morgan Stanley Adjusts Price Target on Patterson Companies to $28 From $30, Maintains Equalweight Rating	MT
20/24/20	JPMorgan Adjusts Price Target on Patterson Companies to $29 From $30, Maintains Neutral Rating	MT
15/24/15	Patterson Faces Investor Concerns Ahead of Earnings Report Due to Leadership Change, Weak Demand, UBS Says	MT
14/24/14	UBS Adjusts Price Target on Patterson Companies to $25 From $28, Maintains Neutral Rating	MT
12/24/12	Patterson Companies Keeps Quarterly Dividend at $0.26 a Share, Payable Aug. 2 to Shareholders of Record July 19	MT
29/24/29	Piper Sandler Downgrades Patterson to Neutral From Overweight, Cuts Price Target to $28 From $34	MT
26/24/26	Leerink Partners Initiates Patterson at Outperform Rating With $36 Price Target	MT
30/23/30	UBS Adjusts Patterson Companies Price Target to $29 From $33, Maintains Neutral Rating	MT
30/23/30	Morgan Stanley Adjusts Price Target on Patterson Companies to $35 From $38, Keeps Equalweight Rating	MT
30/23/30	Goldman Sachs Adjusts Price Target on Patterson Companies to $30 From $35, Keeps Neutral Rating	MT
23/23/23	UBS Adjusts Patterson Companies Price Target to $33 From $27.50, Maintains Neutral Rating	MT
23/23/23	JPMorgan Adjusts Price Target on Patterson to $31 From $29, Maintains Neutral Rating	MT
22/23/22	Morgan Stanley Raises Price Target on Patterson Companies to $38 From $36, Maintains Equal-Weight Rating	MT
22/23/22	Credit Suisse Adjusts Patterson Companies' Price Target to $38 From $35, Keeps Outperform Rating	MT
08/23/08	UBS Adjusts Price Target on Patterson Companies to $27.50 From $29.50, Maintains Neutral Rating	MT
06/23/06	Piper Sandler Adjusts Patterson Companies Price Target to $37 From $35, Maintains Overweight Rating	MT
06/22/06	UBS Adjusts Patterson Companies Price Target to $29.50 From $26, Maintains Neutral Rating	MT
02/22/02	Credit Suisse Raises Patterson Cos.' Price Target to $42 From $39 After Fiscal Q2 Normalized EBIT Tops Consensus, Keeps Outperform Rating	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Analyst Reco. Patterson Companies, Inc.

Equities

PDCO

US7033951036

Medical Equipment, Supplies & Distribution

Analyst Reco.

Filters